Pdt Partners, LLC Castle Biosciences Inc Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $209,010 - $361,620	-5,351 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $144,793 - $186,860	2,408 Added 81.82%	5,351 $356,000
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $386,290 - $592,357	-7,715 Reduced 72.39%	2,943 $216,000
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $627,969 - $1.04 Million	10,658 New	10,658 $730,000
Q4 2020 Feb 16, 2021	SELL	$43.6 - $73.05 $205,617 - $344,503	-4,716 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $181,424 - $245,373	4,716 New	4,716 $243,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.